Go Pro

Fresenius Medical Care AG & Co. KGaA (FMS) Stock Price, News & Analysis

Fresenius Medical Care AG & Co. KGaA logo
$25.35 -0.31 (-1.20%)
Closing price 03:59 PM Eastern
Extended Trading
$25.26 -0.09 (-0.35%)
As of 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Fresenius Medical Care AG & Co. KGaA Stock (NYSE:FMS)

Advanced

Key Stats

Today's Range
$24.65
$26.42
50-Day Range
$20.56
$25.73
52-Week Range
$20.02
$27.64
Volume
1.43 million shs
Average Volume
557,015 shs
Market Capitalization
$13.62 billion
P/E Ratio
13.34
Dividend Yield
2.41%
Price Target
$23.95
Consensus Rating
Reduce

Company Overview

Fresenius Medical Care AG & Co. KGaA is the world’s largest integrated provider of products and services for individuals with renal diseases. The company’s primary business activities encompass the operation of dialysis clinics and the manufacture and distribution of dialysis equipment, dialysis machines, dialyzers, consumables and related therapies. Through its global network of clinics, Fresenius Medical Care delivers comprehensive kidney care, including hemodialysis and peritoneal dialysis treatments, patient education and support services.

In its products segment, the company designs and produces dialysis machines, water treatment systems and disposables such as high‐flux dialyzers and bloodlines. These offerings are complemented by a range of pharmaceuticals, including anticoagulants and iron therapies, along with digital health solutions for remote patient monitoring and data management. By integrating clinical expertise with proprietary technology, Fresenius Medical Care aims to improve treatment outcomes and enhance patient quality of life.

Founded in 1996 as a spin‐off from the Fresenius SE healthcare group, Fresenius Medical Care is headquartered in Bad Homburg, Germany. The company maintains a presence in over 50 countries across North America, Europe, Latin America and the Asia Pacific region. Its global reach is supported by manufacturing facilities, research centers and a network of more than 4,000 dialysis clinics, serving hundreds of thousands of patients worldwide.

AI Generated. May Contain Errors.

Fresenius Medical Care AG & Co. KGaA Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
77th Percentile Overall Score

FMS MarketRank™: 

Fresenius Medical Care AG & Co. KGaA scored higher than 77% of companies evaluated by MarketBeat, and ranked 152nd out of 893 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Fresenius Medical Care AG & Co. KGaA has received a consensus rating of Reduce. The company's average rating score is 1.55, and is based on no strong buy ratings, no buy ratings, 6 hold ratings, and 5 sell ratings.

  • Downside Risk

    Fresenius Medical Care AG & Co. KGaA has a consensus price target of $23.95, representing about 5.5% downside from its current price of $25.35.

  • Amount of Analyst Coverage

    Fresenius Medical Care AG & Co. KGaA has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Fresenius Medical Care AG & Co. KGaA's stock forecast and price target.
  • Earnings Growth

    Earnings for Fresenius Medical Care AG & Co. KGaA are expected to grow by 8.56% in the coming year, from $2.22 to $2.41 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Fresenius Medical Care AG & Co. KGaA is 13.34, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 40.27.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Fresenius Medical Care AG & Co. KGaA is 13.34, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 281.02.

  • Price to Earnings Growth Ratio

    Fresenius Medical Care AG & Co. KGaA has a PEG Ratio of 4.56. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Fresenius Medical Care AG & Co. KGaA has a P/B Ratio of 0.88. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Fresenius Medical Care AG & Co. KGaA's valuation and earnings.
  • Percentage of Shares Shorted

    0.50% of the float of Fresenius Medical Care AG & Co. KGaA has been sold short.
  • Short Interest Ratio / Days to Cover

    Fresenius Medical Care AG & Co. KGaA has a short interest ratio ("days to cover") of 4.51.
  • Change versus previous month

    Short interest in Fresenius Medical Care AG & Co. KGaA has recently decreased by 8.40%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Fresenius Medical Care AG & Co. KGaA pays a meaningful dividend of 2.36%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Fresenius Medical Care AG & Co. KGaA does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Fresenius Medical Care AG & Co. KGaA is 32.11%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Fresenius Medical Care AG & Co. KGaA will have a dividend payout ratio of 25.31% next year. This indicates that Fresenius Medical Care AG & Co. KGaA will be able to sustain or increase its dividend.

  • Read more about Fresenius Medical Care AG & Co. KGaA's dividend.
  • News Sentiment

    Fresenius Medical Care AG & Co. KGaA has a news sentiment score of 1.78. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.72 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 7 news articles for Fresenius Medical Care AG & Co. KGaA this week, compared to 1 article on an average week.
  • Search Interest

    7 people have searched for FMS on MarketBeat in the last 30 days. This is an increase of 600% compared to the previous 30 days.
Receive FMS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fresenius Medical Care AG & Co. KGaA and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

FMS Stock News Headlines

Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Trump has issued emergency support to accelerate the rollout, and it's already live in multiple states. The Financial Times reports Sam Altman is personally calling people to build this for OpenAI. A few little-known companies control the entire supply chain - meaning anyone who wants access must go through them. Their stocks are available to buy right now.tc pixel
FMS Earnings Call Transcripts
See More Headlines

FMS Stock Analysis - Frequently Asked Questions

Fresenius Medical Care AG & Co. KGaA's stock was trading at $23.84 at the beginning of the year. Since then, FMS stock has increased by 6.3% and is now trading at $25.3530.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) posted its earnings results on Tuesday, March, 31st. The company reported $1.05 EPS for the quarter. The business earned $5.34 billion during the quarter. Fresenius Medical Care AG & Co. KGaA had a trailing twelve-month return on equity of 8.90% and a net margin of 4.88%.

Fresenius Medical Care AG & Co. KGaA subsidiaries include these companies: NxStage Medical.

Top institutional investors of Fresenius Medical Care AG & Co. KGaA include GAMMA Investing LLC, Versant Capital Management Inc and Baron Wealth Management LLC.

Shares of FMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Fresenius Medical Care AG & Co. KGaA investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Energy Transfer (ET), AbbVie (ABBV), GE Aerospace (GE) and Adobe (ADBE).

Company Calendar

Last Earnings
3/31/2026
Record date for 6/8 Dividend
5/22/2026
Ex-Dividend for 6/8 Dividend
5/22/2026
Dividend Payable
6/08/2026
Today
8/03/2026
Next Earnings (Estimated)
8/04/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Healthcare Providers & Services
Sub-Industry
Healthcare Services
Current Symbol
NYSE:FMS
CIK
1333141
Employees
1,488
Year Founded
1912

Price Target and Rating

High Price Target
$28.00
Low Price Target
$19.90
Potential Upside/Downside
-5.5%
Consensus Rating
Reduce
Rating Score (0-4)
1.55
Research Coverage
11 Analysts

Profitability

EPS (Trailing Twelve Months)
$1.90
Trailing P/E Ratio
13.34
Forward P/E Ratio
11.42
P/E Growth
4.56
Net Income
$1.11 billion
Net Margins
4.88%
Pretax Margin
7.53%
Return on Equity
8.90%
Return on Assets
4.05%

Debt

Debt-to-Equity Ratio
0.40
Current Ratio
1.20
Quick Ratio
0.86

Sales & Book Value

Annual Sales
$22.20 billion
Price / Sales
0.61
Cash Flow
$5.50 per share
Price / Cash Flow
4.61
Book Value
$28.93 per share
Price / Book
0.88

Miscellaneous

Outstanding Shares
537,130,000
Free Float
N/A
Market Cap
$13.62 billion
Optionable
Optionable
Beta
0.77

Social Links

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

This page (NYSE:FMS) was last updated on 8/3/2026 by MarketBeat.com Staff.
From Our Partners